This report details a study of willingness to pay for oxytocin in the Uniject™ injection system among private midwives in Indonesia. The study also helped to reveal the preferred brands and use of oxytocin, assess the perception of oxytocin in Uniject™ with or without a time-temperature indicator, and identify possible challenges and barriers to market introduction and adoption of oxytocin in Uniject™ in Indonesia.

Publication date: September 2011

Region: Asia

This four-page folio from the Washington Global Health Alliance and the City of Seattle's Office of Economic Development is directed toward businesses interested in developing global health technologies or supporting technologies. It contains case examples and factors for consideration.

Publication date: September 2011

Region: North America and Europe

This fact sheet discusses the development and implementation of technologies to improve the health of women and children in poor and remote areas around the world. It provides examples of PATH’s work in this area.

Publication date: September 2011

Region: Global

Part of series: Oxygen technologies

This report, commissioned by the Washington Global Health Alliance, identifies the global impact of 59 global health organizations in the state of Washington. Highlights from the report include the number of partnerships, number of projects, and number of employees in the global health sector. The report includes detailed graphics and project examples from many of the organizations.

Publication date: September 2011

Region: North America and Europe

This study was an external analysis of the viability of supporting oxytocin in the Uniject™ injection system as a niche product in both the public and private sectors globally. A major component of this analysis was to conduct separate market analyses of 30 countries identified by the US Agency for International Development as priority countries for maternal health interventions.

Publication date: June 2011

Region: Global

The Reproductive Health Supplies Coalition is a global partnership dedicated to making essential reproductive health products available in low- and middle-income countries. As the Coalition’s administrative and operative arm, the Secretariat works to ensure that our partnership functions smoothly and achieves its goals. This report highlights key successes achieved in 2010.

Publication date: 2011

Region: Global

It is widely recognized today that ensuring a reliable supply of quality contraceptives is essential to reproductive health programs. The tagline "No product? No program" is known, understood, and embraced by those working to support reproductive health in the developing world. But this was not always the case. This paper tells the story of how what was once seen only as a technical issue became a global movement.

Author: Solo J

Publication date: 2011

Region: Global

This second annual policy report from the Global Health Technologies Coalition—a group of almost 40 nonprofit organizations working to increase awareness of the urgent need for vaccines, diagnostics, drugs, microbicides, and other products that save lives in the developing world—outlines some of the steps that will help curb unnecessary deaths, extend lives, and secure healthier futures. Serving as a guide for policymakers, the report documents promising policy actions taken over the past year in the areas of US investments in global health and international development, regulatory pathways to ensure the safety and efficacy of health tools, and incentives and innovative financing mechanisms to spur global health product development. This report offers recommendations for how US policymakers can continue to have a lead in improving health worldwide.

Publication date: 2011

Region: North America and Europe

Part of series: GHTC's annual policy reports

This fact sheet from the Global Health Technologies Coalition examines how research for new global health tools can help achieve the Millennium Development Goals.

Publication date: September 2010

Region: Global

This fact sheet from the Global Health Technologies Coalition examines the role of innovation in international development and makes recommendations to elevate global health research in the foreign aid reform process.

Publication date: July 2010

Region: North America and Europe

This publication describes the public health potential of multipurpose prevention technologies -- that is, technologies that prevent unintended pregnancy; sexually transmitted infections, including HIV; and/or other reproductive tract infections. While a few such technologies exist, greater collaboration and resources are needed to accelerate research and development efforts and bring new technologies into widespread use.

Author: Holt BY, Kilbourne-Brook M, Cohen J, Burns M

Publication date: May 2010

Region: Global

The purpose of this cost analysis study conducted at six health facilites was to determine the costs of replacing the existing delivery method with oxytocin in Uniject® for the prevention of postpartum hemorrhage. This study complements a larger study on acceptability and feasibility, Pilot Introduction of Oxytocin in Uniject® During Active Management of the Third Stage of Labor (AMTSL) at the Institutional Level in Guatemala.

Publication date: March 2010

Region: Latin America

This report shares the results of a pilot introduction of oxytocin in the Uniject® device for use with active management of the third stage of labor that was conducted at the institutional level in Guatemala in 2009. Results include details on the feasibility of introducing oxytocin in Uniject in this context as well as the acceptability of this technology among health care providers and facility managers. The cost analysis can be found here.

Publication date: March 2010

Region: Latin America

This report, the first annual policy report of the Global Health Technologies Coalition, makes recommendations for Congress and the Obama Administration to ensure that the United States maximizes its investment in global health and continues as a leader in global health research and development. The report makes recommendations in three areas: public financing, regulatory pathways, and incentives and innovative financing.

Publication date: 2010

Region: North America and Europe

Part of series: GHTC's annual policy reports

Improving iron status among infants and young children is of continued concern in low- to middle-income countries. This article, published in The Journal of Nutrition, reports on a double-blind, randomized trial among mildly anemic children in Brazil that compared use of rice fortified with micronized ferric pyrophosphate using the Ultra Rice technology with identical nonfortified rice. The study found that, in populations where young children are routinely fed approximately 100 grams of cooked rice daily, fortifying rice with iron may improve iron status at least as well as providing free iron drops.

Author: Beinner M, Velasquez-Meléndez G, Pessoa MC, Greiner T

Publication date: November 2009

Region: Global

This compilation contains key references and resources to aid program planners in the introduction of oxytocin in the Uniject™ prefilled injection device.

Publication date: September 2009

Region: Global

This case study highlights PATH's work with the Global Alliance for Improved Nutrition and the Naandi Foundation to introduce rice fortified with iron-enriched grains into the government of India's Mid-day Meal Scheme in Vishakhapatnam, Andhra Pradesh. The fortified rice was served daily for one school year to 60,000 children under the government-sponsored Mid-day Meal Scheme. A peer-reviewed study found that school children in India between the ages of 5 and 12 years who ate fortified rice had a significant increase in iron stores.

Publication date: June 2009

Region: Global

This paper was commissioned as an introductory landscape analysis for the aids2031 Science and Technology Working Group as part of a series of working papers under the aids2031 initiative. The paper builds on other recent landscape analysis work in the fields of HIV prevention technologies, therapeutics, and diagnostics and is intended to serve as a resource on the current status of research and development for biomedical and other technological interventions to prevent, treat, and diagnose HIV/AIDS.

Author: Alcorn K

Publication date: October 2008

Region: Global

Part of series: aids2031 working papers

This document provides important details on technical aspects of the Ultra Rice® technology.

Publication date: October 2008

Region: Global

This overview has been developed for program planners considering introduction and/or expansion of the use of oxytocin, and in particular oxytocin packaged in the Uniject™ device, to reduce the incidence of postpartum hemorrhage as a component of their maternal and child health programming. Administering oxytocin is just one component of active management of third stage labor.

Publication date: September 2008

Region: Global